Local Institution - 0089 — Southington, Connecticut

Local Institution - 0089 is a clinical research site located in Southington, Connecticut, United States 06489.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 0089 has participated in 1 clinical trials.

Therapeutic areas: Chronic Phase Chronic Myeloid Leukemia.

Sponsors: Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Southington

Browse all research sites in Connecticut · View every site in Southington

• Cancer Center of Central Connecticut
• Research Site
• Novartis Investigative Site
• Local Institution - 010
• Cancer Center of Central Connecticut - Southington
• Teva Investigational Site 67
• Cancer Centers of Connecticut Southington Location
• ImClone Investigational Site
• Local Institution - 153
• Cancer Center of Central Conn.
• Hartford Healthcare CT

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0089?

Local Institution - 0089 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0089 conducted?

Local Institution - 0089 has 1 clinical trials on record. Their work covers Chronic Phase Chronic Myeloid Leukemia.

Is Local Institution - 0089 accredited by Crixeo Clinical Trials?

Local Institution - 0089 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0089?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.